A patient with embryonal rhabdomyosarcoma, zccs170 (high FGFR4, AKT2, and MAP2K2 mRNA expression), experienced a PR to temsirolimus/vinorelbine/cyclo. This evidence concerns the gene AKT2 and embryonal rhabdomyosarcoma.